Indications and Purposes
| 1 Indications And Usage Ingrezza Is Indicated For The Treatment Of Adults With Tardive Dyskinesia [See Clinical Studies ( 14 )]. Ingrezza Is A Vesicular Monoamine Transporter 2 (Vmat2) Inhibitor Indicated For The Treatment Of Adults With Tardive Dyskinesia. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Valbenazine |
|
ZINC43195697 |